Get the latest tech news
Ozempic increases risk of debilitating eye condition: studies
Two independent studies from the University of Southern Denmark (SDU) show that patients with type 2 diabetes who are treated with the drug Ozempic have an increased risk of developing damage to the optic nerve of the eye, which can lead to severe and permanent loss of vision. Both studies are based on Danish registers and are the largest in the world.
As was the case for Jakob Grauslund, we found that the risk of developing NAION doubles if you take Ozempic, explains Anton Pottegård, Professor of Pharmaceuticals at the Department of Public Health. - It is extremely important that type 2 diabetes is treated, but you have to consider whether the small increased risk of severe vision loss by using Ozempic means that you should instead use one of the other new drugs that protect against kidney and cardiovascular disease. Jakob Grauslund: Once-weekly semaglutide doubles the five-year risk of nonarteritic anterior ischemic optic neuropathy in a Danish cohort of 424,152 persons with type 2 diabetes.
Or read this on Hacker News
